XML 32 R20.htm IDEA: XBRL DOCUMENT

Note 4 - Acquisition (Tables)

3 Months Ended

Mar. 31, 2016

Notes Tables

Business Combination, Preliminary Purchase Price Consideration [Table Text Block]

Purchase consideration
Fair value of RestorGenex shares outstanding		$	19,546,000
Estimated fair value of RestorGenex stock options assumed by Diffusion			1,321,000
Estimated fair value of RestorGenex warrants assumed by Diffusion			384,000
Contingent value rights – RES-440 product candidate			10,000
Total preliminary purchase price		$	21,261,000

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]

Cash and cash equivalents		$	8,500,602
Prepaid expenses and other assets			195,200
Property and equipment			57,531
Intangible assets			9,317,000
Goodwill			7,105,031
Accrued liabilities			(377,431	)
Deferred tax liability			(3,536,933	)
Net assets acquired		$	21,261,000

Schedule of Finite-Lived Intangible Assets [Table Text Block]

		March 31, 2016												December 31, 2015
		Gross Carrying Amount				Accumulated Amortization				Intangible Assets, net				Gross Carrying Amount				Accumulated Amortization				Intangible Assets, net
RES-529		$	8,385,000			$	0			$	8,385,000			$	0			$	0			$	0
RES-440		$	932,000			$	0			$	932,000			$	0			$	0			$	0
Total in-process research and development costs (IPR&D)		$	9,317,000			$	0			$	9,317,000			$	0			$	0			$	0

Business Acquisition, Pro Forma Information [Table Text Block]

		Three Months Ended March 31, 2016				Three Months Ended March 31, 2015
Net revenues		$	0			$	0
Net loss		(4,655,944		)		(4,759,901		)
Basic and diluted loss per share		$	(0.05	)		$	(0.12	)